Aron R. English bought $10.0M of Anebulo Pharmaceuticals (ANEB)

Executed Dec 23 2024, disclosed Dec 26 2024, 3 days later.

Value, as filed

$10.0M

10,101,010 sh × $0.99

Executed

Dec 23 2024

the trade date, as filed

Disclosed

Dec 26 2024

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+3.4%

+48.1% from execution

Over the 21 trading sessions from the disclosed entry session (Dec 26 2024), the stock returned +3.4% (delay-adjusted); from the execution session (Dec 23 2024), +48.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

AE Aron R. English Director profile →

Aron R. English (Director) filed 2 Form 4 reports in the past 24 months (1 purchase, 1 sale), most often in ANEB. Across 1 priced purchase filing, the average 21-session return was +48.1% from execution and +3.4% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of ANEB (10,101,010 sh × $0.99, as filed), executed Dec 23 2024.

The name

ANEB ANEB ANEB · 1 filing in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→